Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tomoki is a Japanese biotechnology company specializing in the development of advanced microfluidic technologies for cell processing and analysis. The company's core business revolves around its proprietary platform designed to automate and standardize the preparation of high-quality cell products for therapeutic use. By integrating microfluidics with biotechnology, Tomoki aims to enhance the efficiency of cell therapy manufacturing and regenerative medicine applications. Their services include providing specialized equipment and consumables for research and clinical laboratories focused on oncology and immunology. Tomoki is positioned as a key technology provider in the rapidly growing field of personalized medicine and cell-based diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tomoki.